Cargando…
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
BACKGROUND: The novel coronavirus disease (2019-nCoV) has been affecting global health since the end of 2019 and there is no sign that the epidemic is abating . The major issue for controlling the infectious is lacking efficient prevention and therapeutic approaches. Chloroquine (CQ) and Hydroxychlo...
Autores principales: | Wang, Nan, Han, Shengli, Liu, Rui, Meng, Liesu, He, Huaizhen, Zhang, Yongjing, Wang, Cheng, Lv, Yanni, Wang, Jue, Li, Xiaowei, Ding, Yuanyuan, Fu, Jia, Hou, Yajing, Lu, Wen, Ma, Weina, Zhan, Yingzhuan, Dai, Bingling, Zhang, Jie, Pan, Xiaoyan, Hu, Shiling, Gao, Jiapan, Jia, Qianqian, Zhang, Liyang, Ge, Shuai, Wang, Saisai, Liang, Peida, Hu, Tian, Lu, Jiayu, Wang, Xiangjun, Zhou, Huaxin, Ta, Wenjing, Wang, Yuejin, Lu, Shemin, He, Langchong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467095/ https://www.ncbi.nlm.nih.gov/pubmed/32920291 http://dx.doi.org/10.1016/j.phymed.2020.153333 |
Ejemplares similares
-
Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021) -
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021) -
Harringtonine: A more effective antagonist for Omicron variant
por: Hu, Shiling, et al.
Publicado: (2023) -
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021) -
A novel tissue model for angiogenesis: evaluation of inhibitors or promoters in tissue level
por: Dai, Bingling, et al.
Publicado: (2014)